Literature DB >> 26398690

CORRELATION OF OPTICAL COHERENCE TOMOGRAPHY AND MACULAR PIGMENT OPTICAL DENSITY MEASUREMENTS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Meike B Zeimer1, Ferenc B Sallo, Georg Spital, Britta Heimes, Albrecht Lommatzsch, Daniel Pauleikhoff.   

Abstract

PURPOSE: Macular telangiectasia is associated with neurodegenerative changes including focal outer retinal atrophy and a loss of macular pigment (MP). We aimed to investigate whether an association between spectral domain optical coherence tomography neurodegenerative signs and MP abnormalities can be detected.
METHODS: Forty-seven eyes of 27 macular telangiectasia Type 2 patients (mean age 66.7 years, range 50-82 years, 12 male) were investigated. An MP pattern was recorded using a dual-wavelength autofluorescence method and classified according to severity (I-III). Outer plexiform, inner nuclear, and photoreceptor layer thickness values were measured in Spectralis spectral domain optical coherence tomography scans. Thickness values were compared with those of a control group of 14 healthy age-matched eyes.
RESULTS: Macular pigment redistribution was found to be Class I in 11 eyes, Class II in 28 eyes, and Class III in 8 eyes. More advanced stages of MP loss were associated with a greater, statistically significant thinning of the outer plexiform and inner nuclear layer complex and photoreceptor layers (P ≤ 0.001). Lower absolute levels of MP were also associated with a thinning of the photoreceptor layer. Thinning was restricted to within the parafovea, more severe at temporal eccentricities.
CONCLUSION: Our findings support the hypothesis that in macular telangiectasia Type 2 cellular degenerative processes leading to a thinning of these layers also result in reduction and redistribution of MP.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26398690     DOI: 10.1097/IAE.0000000000000752

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  3 in total

1.  Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity.

Authors:  Ramyaa Srinivasan; Michel M Teussink; Kenneth R Sloan; Rekha Priya Kalluri Bharat; Raja Narayanan; Rajiv Raman
Journal:  BMC Ophthalmol       Date:  2022-06-13       Impact factor: 2.086

Review 2.  Imaging endpoints for clinical trials in MacTel type 2.

Authors:  Daniel Pauleikhoff; Laurenz Pauleikhoff; Emily Y Chew
Journal:  Eye (Lond)       Date:  2021-08-13       Impact factor: 3.775

3.  Relevance of Multicolor Imaging in Type 2 Macular Telangiectasia.

Authors:  Ramesh Venkatesh; Arpitha Pereira; Bharathi Bavaharan; Kushagra Jain; Aditya Aseem; Sajjan Sangai; Naresh Kumar Yadav
Journal:  J Curr Ophthalmol       Date:  2020-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.